Cardiac involvement has been described in Severe Acute Respiratory Syndrome - Coronavirus-2 (SARS-CoV-2) infection. Although there are no approved drugs to prevent or treat SARS-CoV-2 infection at present time, several medications used have the potential to increase QT interval and eventually provoke torsades de pointe. The investigators therefore create a study that include all patients with SARS-CoV-2 infection having an electrocardiogram (ECG). The investigators evaluate the percentage of patients with ECG abnormalities, describe the abnormalities and evaluate the occurrence of syncope, ventricular arrhythmia and corrected QT (cQT) interval modification in patients receiving treatment.
In patients with SARS-CoV-2 infection, the investigators analyze baseline ECG as well as follow-up ECG. Patients followed by Bordeaux University Hospital for COVID-19 can be included. ECG are digitized in the computerized patient file (DxCARE) for further analysis.
Study Type
OBSERVATIONAL
Enrollment
196
Baseline ECG as well as follow-up ECG are analysed
Baseline treatment data as well as follow-up treatment data are collected
Baseline Biological check-up data as well as follow-up data are collected
Clinical events of interest at the baseline as well as follow-up clinical events are collected
Bordeaux University Hospital
Pessac, France
Proportion of ECGs abnormalities in patients SARS-CoV-2 infection
Percentage of ECGs with abnormalities
Time frame: Day 0
Evolution of PR, QRS and cQT interval
The evolution of interval is measured in seconds for patients receiving drugs interfering with cardiac electrophysiology for SARS-CoV-2 infection
Time frame: Baseline and 1 month
Rate of syncope during treatment
The number of syncope is measured during the treatment
Time frame: Baseline and 1 month
Rate of cardiac death during treatment
The number of cardiac death is measured during the treatment
Time frame: Baseline and 1 month
Rate of arrhythmia during treatment
The number of arrhythmia is measured during the treatment
Time frame: Baseline and 1 month
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.